BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
Fatty acid metabolic process
,
Lung cancer
,
Adipose tissue
,
Nosology
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
heart neoplasms
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Neoplasms
OMIM - Congenital disorder
Breast, endometrial and ovarian cancer cell lines treated with eribulin or paclitaxel
Single cell analysis of brain in cancer, COPD, COVID-19, heart disease, and influenza
OMIM - Vascular disease
Explore Curated Studies Results
Literature
Most Relevant Literature
Scope of PET imaging in the evaluation of cardiac tumors.
Multiparametric mapping by cardiovascular magnetic resonance imaging in cardiac tumors.
Cardiac tumor comprising a malignant peripheral nerve sheath tumor and spontaneous atrial osseous me…
A dangling right heart tumour.
Radiomics Feature Analysis Using Native T1 Mapping for Discriminating Between Cardiac Tumors and Thr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Cabozantinib in High Grade Neuroendocrine Neoplasms
Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ